Viking Therapeutics Inc

0.00 (0.0%)

Viking Therapeutics Financial Summary

The current 0VQA market cap is 0. The company's latest EPS is -0.905 and P/E is -25.35.

Year End 31 December 20182019202020212022
Total Revenue 00000
Operating Income -26.16M-32.69M-42.66M-55.68M-70.36M
Net Income -22.06M-25.78M-39.5M-54.99M-68.87M
Year End 31 December 20182019202020212022
Total Assets 302.31M284.26M256.5M210.66M168.53M
Total Liabilities 4.56M7.14M12.16M8.78M23.21M
Total Equity 297.75M277.12M244.34M201.88M145.32M
Year End 31 December 20182019202020212022
Operating -18.76M-24.75M-21.78M-47.59M-48.4M
Investing -265.73M7.46M41.57M37.96M54.75M
Financing 300.28M887k950k6.88M4.16M
Market Cap 0
Price to Earnings Ratio -25.35
Price to Sales Ratio
Price to Cash Ratio 48.06
Price to Book Ratio 12.08
Dividend Yield -

Share Statistics

Shares Outstanding 76.06M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Viking Therapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.vikingtherapeutics.com
Industry pharmaceutical preparations (2834)
Your Recent History
Viking The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230606 18:35:58